Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Peptides|January 1, 1997
Analysis of NPY receptor subtypes in the human frontal cortex reveals abundant Y1 mRNA and binding sitesM A Statnick, D A Schober, N G Mayne, et al.
Journal of Helminthology|February 11, 2010
A serological study of Dirofilaria immitis in feral cats in Grenada, West IndiesC Fernandez, A Chikweto, S Mofya, et al.
European Journal of Pharmacology|December 30, 1996
The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptorsD R Gehlert, S L Gackenheimer, D A Schober, et al.
Neuropharmacology|July 29, 1998
Sulphur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell linesA E Kingston, J Lowndes, N Evans, et al.
Brain Research|November 14, 1998
Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sitesM A Statnick, D A Schober, S Gackenheimer, et al.
Neuropharmacology|August 1, 1995
Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4- dicarboxylateD D Schoepp, B G Johnson, C R Salhoff, et al.
Neuropharmacology|July 29, 1998
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsA E Kingston, P L Ornstein, R A Wright, et al.
Neuropharmacology|January 1, 1996
The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptorsD D Schoepp, C R Salhoff, R A Wright, et al.
Brain Research. Brain Research Protocols|August 1, 1997
Preparation and purification of antibodies specific to human neuronal voltage-dependent calcium channel subunitsR E Beattie, S G Volsen, D Smith, et al.
Neuropharmacology|January 1, 1997
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptorsD D Schoepp, B G Johnson, R A Wright, et al.
Pageof 3